ESC 365 - How did a three-year tafamidis therapy course affect our patient's life?

Open Access

How did a three-year tafamidis therapy course affect our patient's life?

Session: Effecting one’s future treatment in chronic heart failure

Topic: Clinical

Speaker: Doctor N. Gataric (Belgrade, RS)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Nina Gataric

University Clinical Center of Serbia, Belgrade (Serbia)

2 presentations

0 follower

2 more presentations in this session

Improved ejection fraction following optimised treatment for heart failure with reduced ejection fraction in a patient with dilated cardiomyopathy and TNNT2 mutation

Speaker: Doctor B. Arruda (Sao Paulo, BR)

Sacubitril/valsartan dose escalation in a patient with low blood pressure and a history of orthostatic syncope under controlled remote monitoring of vital signs

Speaker: Doctor A. Drohomirecka (Warsaw, PL)

Access the full session

Effecting one’s future treatment in chronic heart failure

Speakers: Doctor N. Gataric, Doctor B. Arruda, Doctor A. Drohomirecka

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources